Idylla

Device Biocartis US, Inc
Total Payments
$31,589
Transactions
53
Doctors
36
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2023 $8,200 22 16
2022 $22,889 30 22
2021 $500.00 1 1

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $17,241 2 54.6%
Food and Beverage $6,027 45 19.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,000 2 12.7%
Travel and Lodging $3,821 3 12.1%
Compensation for serving as faculty or as a speaker for a medical education program $500.00 1 1.6%

Payments by Type

Research
$17,241
2 transactions
General
$14,348
51 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Validation and comparison of the Idylla GeneFusion Assay for the detection of RET in thyroid cancer Biocartis US, Inc $15,190 0
IDH Early Access Biocartis US, Inc $2,051 0

Top Doctors Receiving Payments for Idylla — Page 2

Doctor Specialty Location Total Records
, ARNP Acute Care Jacksonville, FL $15.73 1
, MD Anatomic Pathology & Clinical Pathology Jacksonville, FL $15.73 1
, MD Anatomic Pathology & Clinical Pathology Jacksonville, FL $15.73 1
, M.D Student in an Organized Health Care Education/Training Program Jacksonville, FL $15.73 1
, PA-C Medical Jacksonville, FL $15.73 1
, MD Hematology Gainesville, FL $11.00 2
, MD Hematology East Point, GA $8.51 1
, MD, PHD Anatomic Pathology & Clinical Pathology Alpharetta, GA $8.51 1
, M.D Hematology Gainesville, FL $6.55 1
, MD Hematology Gainesville, FL $6.55 1
, MD Medical Oncology Gainesville, FL $6.55 1
, M.D Family Medicine North Miami Beach, FL $4.64 1

About Idylla

Idylla is a device associated with $31,589 in payments to 36 healthcare providers, recorded across 53 transactions in the CMS Open Payments database. The primary manufacturer is Biocartis US, Inc.

Payment data is available from 2021 to 2023. In 2023, $8,200 was paid across 22 transactions to 16 doctors.

The most common payment nature for Idylla is "Unspecified" ($17,241, 54.6% of total).

Idylla is associated with 2 research studies, including "Validation and comparison of the Idylla GeneFusion Assay for the detection of RET in thyroid cancer" ($15,190).